PDZ and LIM Domain 4 (PDLIM4) (N-Term) Peptide
PDLIM4
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5513139
Aperçu rapide pour PDZ and LIM Domain 4 (PDLIM4) (N-Term) Peptide (ABIN5513139)
Antigène
PDLIM4
(PDZ and LIM Domain 4 (PDLIM4))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Séquence
- LRGPSPWGFR LVGGRDFSAP LTISRVHAGS KAALAALCPG DLIQAINGES
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-PDLIM4 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PDLIM4 (PDZ and LIM Domain 4 (PDLIM4))
-
Sujet
-
This gene encodes a protein which may be involved in bone development. Mutations in this gene are associated with susceptibility to osteoporosis.
Alias Symbols: RIL
Protein Size: 330 -
ID gène
- 8572
-
NCBI Accession
- NM_001131027, NP_001124499
-
UniProt
- P50479
Antigène
-
Vous êtes ici:
